UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029851
Receipt number R000034036
Scientific Title A randomised controlled trial of ACAT, a psychoeducational programme for young people with high-functioning autism spectrum disorder and their families.
Date of disclosure of the study information 2018/01/06
Last modified on 2021/03/25 11:21:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomised controlled trial of ACAT, a psychoeducational programme for young people with high-functioning autism spectrum disorder and their families.

Acronym

A randomised controlled trial of ACAT

Scientific Title

A randomised controlled trial of ACAT, a psychoeducational programme for young people with high-functioning autism spectrum disorder and their families.

Scientific Title:Acronym

A randomised controlled trial of ACAT

Region

Japan


Condition

Condition

High-functioning Autism Spectrum Disorders

Classification by specialty

Pediatrics Psychiatry Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of psychoeducational program based cognitive behavioral therapy for autism spectrum disorders (10-17 years) and their parents. Half were randomly assigned to program, and compared with the others receiving no additional intervention. ASD-related self-awareness, the primary outcome, was evaluated using the bespoke Autism Knowledge Quiz.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

The section 1 in the Autism Knowledge Quiz for young people

Key secondary outcomes

For patient: Barriers to Access to Care Evaluation 3rd Edition,Strengths and Difficulties Questionnaire ,Vineland-2,DSRS-C, EEG, self understanding questionarie.
For parents: Barriers to Access to Care Evaluation, Autism Knowledge Quiz for Parent,Parenting Resilience Elements Questionnaire,GHQ12, EEG.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Cognitive behavior therapy

Interventions/Control_2

Treatment as Usual

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

17 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Individual with who have diagnosis of autism spectrum disorder.
2)Verbal intelligence quotient of patients is over 90.
3)Individual with who are above "some need" in Strengths & Difficulties Questionnaires.
4)Age of patients is over 10 to 17 year
5)Caregivers can attend their CBT session with patients.
6)Individual with who have "treatment as usual" does not add an new treatment.
7)Patients can understand CBT.
8)The patients who are diagnosed anxiety disorder and depression can attend this study if they are primaly diagnosed of ASD.
9)Caregivers should not have any psychiatric deseases.
10)Caregivers can attend each CBT session with patients.

Key exclusion criteria

1)Individual with who have an organic disorder
2)Individual with who have suicidal atempt.
3)Individual with who have antisocial conditions.
4)Individual with who have serious psycical disorder.
5)Individual with who have low IQ(under 90 of VIQ)
6)Individual with whoes caregivers cannot attend the sessions.


Target sample size

48


Research contact person

Name of lead principal investigator

1st name Eiji
Middle name
Last name Shimizu

Organization

Chiba University

Division name

Research Center for Child Mental Development

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba, Japan

TEL

043-226-2975

Email

eiji@faculty.chiba-u.jp


Public contact

Name of contact person

1st name Oshima
Middle name
Last name Fumiyo

Organization

Chiba University

Division name

Research Center for Child Mental Development

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba, Japan

TEL

043-226-2975

Homepage URL


Email

f_oshima@chiba-u.jp


Sponsor or person

Institute

Chiba University

Institute

Department

Personal name



Funding Source

Organization

Japanese Clinical Psychology Institute

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor

Osaka University
Hamamatsu Medical University
Fukusima University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba University Clinical Research Ethical Review Committee

Address

1-8-1 Inohana Chioku Chiba

Tel

043-226-2630

Email

ayamazaki@office.chiba-u.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

G29027

Org. issuing International ID_1

Chiba University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 06 Day


Related information

URL releasing protocol

https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04750-z

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

49

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 01 Day

Date of IRB

2017 Year 10 Month 01 Day

Anticipated trial start date

2018 Year 02 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 12 Month 31 Day

Date trial data considered complete

2020 Year 12 Month 31 Day

Date analysis concluded

2021 Year 01 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 11 Month 07 Day

Last modified on

2021 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034036


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name